06978

0.3203.03%
HH

Hu Huaizhong

Chief Scientist

Dr. Hu Huaizhong is Chief Scientist of Immunotech Biopharm Ltd from 2026. As the Chief Scientific Officer of Beijing Immunotech Biopharm, he boasts profound expertise in innovative drug research and development as well as clinical trials, with a particular focus on the T cell therapy field. He has successfully developed and commercialized a number of innovative biologics targeting T cells and in vitro diagnostic kits. He has published over 60 research articles in peer-reviewed biomedical journals and holds over 20 invention patents. He has extensive research experience and outstanding academic achievements. He is a renowned expert in immunology and toxicology. He obtained his Doctor of Medicine from West China University of Medical Sciences and Doctor of Philosophy in Immunology from Utrecht University in the Netherlands and completed his postdoctoral research at the National Institutes of Health (NIH) in the United States. He holds the Diplomate of the American Board of Toxicology (DABT) certification and is a member of both the American Association of Immunologists and the Society of Toxicology. He has been selected for Beijing’s Overseas High-Level Talent Program and Chaoyang District’s Phoenix Talent Program. He serves as a Standing Committee Member of the Biotechnological Drug Professional Committee and the Immunotoxicology Professional Committee of the Chinese Society of Toxicology.

Positions